Sonoma Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.933; its P/E ratio is -0.18; Sonoma Pharmaceuticals is scheduled to report earnings on July 10, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 3.14M	$ 2.73M	$ 3.43M	$ 3.01M	$ 2.94M
Gross Profit	$ 1.46M	$ 990.00K	$ 1.20M	$ 864.00K	$ 831.00K
EBIT	$ -923.00K	$ -1.30M	$ -1.45M	$ -1.45M	$ -1.91M
EBITDA	$ -878.00K	$ -1.25M	$ -1.41M	$ -1.42M	$ -1.87M
Net Income Common Stockholders	$ -866.00K	$ -1.48M	$ -1.42M	$ -1.31M	$ -1.94M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 2.41M	$ 2.14M	$ 3.54M	$ 3.82M	$ 2.63M
Total Assets	$ 14.62M	$ 13.63M	$ 15.89M	$ 16.23M	$ 13.93M
Total Debt	$ 385.00K	$ 522.00K	$ 655.00K	$ 849.00K	$ 486.00K
Net Debt	$ -2.02M	$ -1.61M	$ -2.89M	$ -2.97M	$ -2.15M
Total Liabilities	$ 7.93M	$ 7.96M	$ 8.65M	$ 8.25M	$ 8.37M
Stockholders Equity	$ 6.69M	$ 5.67M	$ 7.24M	$ 7.98M	$ 5.56M
Cash Flow	-
Free Cash Flow	$ -1.10M	$ -1.23M	$ -232.00K	$ -2.63M	$ -379.00K
Operating Cash Flow	$ -1.10M	$ -1.23M	$ -215.00K	$ -2.44M	$ -348.00K
Investing Cash Flow	$ -1.00K	$ -2.00K	$ -17.00K	$ -82.00K	$ 34.00K
Financing Cash Flow	$ 1.32M	$ -129.00K	$ -135.00K	$ 3.37M	$ -318.00K

Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Income Statement >

Sonoma Pharmaceuticals Debt to Assets

Balance Sheet >

Sonoma Pharmaceuticals Cash Flow

Cash Flow >

Sonoma Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing